FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2569612930> ?p ?o ?g. }

• W2569612930 endingPage "e013967" @default.
• W2569612930 startingPage "e013967" @default.
• W2569612930 abstract "<h3>Introduction</h3> Attention-deficit/hyperactivity disorder (ADHD) is a major public health issue. Pharmacological treatments play an important role in the multimodal treatment of ADHD. Currently, there is a lack of up-to-date and comprehensive evidence on how available ADHD drugs compare and rank in terms of efficacy and tolerability, in children or adolescents as well as in adults. We will conduct a network meta-analysis (NMA), integrating direct and indirect comparisons from randomised controlled trials (RCTs), to rank pharmacological treatments for ADHD according to their efficacy and tolerability profiles. <h3>Methods and analysis</h3> We will search a broad range of electronic databases, including PubMed, MEDLINE, EMBASE, PsycINFO, ERIC and Web of Science, with no date or language restrictions. We will also search for unpublished studies using international clinical trial registries and contacting relevant drug companies. We will identify and include available parallel-group, cross-over and cluster randomised trials that compare methylphenidate, dexmethylphenidate, amphetamine derivatives (including lisdexamfetamine), atomoxetine, clonidine, guanfacine, bupropion or modafinil (as oral therapy) either with each other or to placebo, in children, adolescents or adults with ADHD. Primary outcomes will be efficacy (indicated by reduction in severity of ADHD core symptoms measured on a standardised scale) and tolerability (the proportion of patients who left a study early due to side effects). Secondary outcomes will be global functioning, acceptability (proportion of patients who left the study early by any cause) and changes in blood pressure and body weight. NMA will be conducted in STATA within a frequentist framework. The quality of RCTs will be evaluated using the Cochrane risk of bias tool, and the quality of the evidence will be assessed using the GRADE approach. Subgroup and sensitivity analyses will be conducted to assess the robustness of the findings. <h3>Ethics and dissemination</h3> No ethical issues are foreseen. Results from this study will be published in a peer-reviewed journal and possibly presented at relevant national and international conferences. <h3>Trial registration number</h3> CRD42014008976." @default.
• W2569612930 created "2017-01-13" @default.
• W2569612930 creator A5000680159 @default.
• W2569612930 creator A5007077090 @default.
• W2569612930 creator A5016008616 @default.
• W2569612930 creator A5032283932 @default.
• W2569612930 creator A5033015949 @default.
• W2569612930 creator A5035412334 @default.
• W2569612930 creator A5039199295 @default.
• W2569612930 creator A5046848920 @default.
• W2569612930 creator A5048073152 @default.
• W2569612930 creator A5052792299 @default.
• W2569612930 creator A5053809343 @default.
• W2569612930 creator A5059434405 @default.
• W2569612930 creator A5063885814 @default.
• W2569612930 creator A5069771666 @default.
• W2569612930 creator A5072713706 @default.
• W2569612930 creator A5076676344 @default.
• W2569612930 creator A5088155902 @default.
• W2569612930 creator A5091022154 @default.
• W2569612930 date "2017-01-01" @default.
• W2569612930 modified "2023-10-14" @default.
• W2569612930 title "Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis" @default.
• W2569612930 cites W1506520709 @default.
• W2569612930 cites W1519950850 @default.
• W2569612930 cites W1552630832 @default.
• W2569612930 cites W1591259115 @default.
• W2569612930 cites W1617328014 @default.
• W2569612930 cites W1751633684 @default.
• W2569612930 cites W1929285963 @default.
• W2569612930 cites W1964162160 @default.
• W2569612930 cites W1966223858 @default.
• W2569612930 cites W1970632441 @default.
• W2569612930 cites W1972551153 @default.
• W2569612930 cites W1979424131 @default.
• W2569612930 cites W1996091936 @default.
• W2569612930 cites W1998962049 @default.
• W2569612930 cites W2004474087 @default.
• W2569612930 cites W2010073589 @default.
• W2569612930 cites W2010699829 @default.
• W2569612930 cites W2014553305 @default.
• W2569612930 cites W2016511885 @default.
• W2569612930 cites W2016880798 @default.
• W2569612930 cites W2021188640 @default.
• W2569612930 cites W2036696167 @default.
• W2569612930 cites W2037593179 @default.
• W2569612930 cites W2037665165 @default.
• W2569612930 cites W2040557955 @default.
• W2569612930 cites W2048386311 @default.
• W2569612930 cites W2066232148 @default.
• W2569612930 cites W2074147400 @default.
• W2569612930 cites W2078112157 @default.
• W2569612930 cites W2083674804 @default.
• W2569612930 cites W2085046856 @default.
• W2569612930 cites W2085803274 @default.
• W2569612930 cites W2085805157 @default.
• W2569612930 cites W2091808438 @default.
• W2569612930 cites W2095548026 @default.
• W2569612930 cites W2096883889 @default.
• W2569612930 cites W2102780372 @default.
• W2569612930 cites W2107328434 @default.
• W2569612930 cites W2108571276 @default.
• W2569612930 cites W2109051507 @default.
• W2569612930 cites W2111086327 @default.
• W2569612930 cites W2112318790 @default.
• W2569612930 cites W2114290463 @default.
• W2569612930 cites W2116222360 @default.
• W2569612930 cites W2117104588 @default.
• W2569612930 cites W2125435699 @default.
• W2569612930 cites W2127901933 @default.
• W2569612930 cites W2129821518 @default.
• W2569612930 cites W2130235475 @default.
• W2569612930 cites W2131099228 @default.
• W2569612930 cites W2131342243 @default.
• W2569612930 cites W2131701504 @default.
• W2569612930 cites W2133531206 @default.
• W2569612930 cites W2140548090 @default.
• W2569612930 cites W2141784450 @default.
• W2569612930 cites W2149154629 @default.
• W2569612930 cites W2171074660 @default.
• W2569612930 cites W2171147935 @default.
• W2569612930 cites W2176259088 @default.
• W2569612930 cites W2271530710 @default.
• W2569612930 cites W2320331035 @default.
• W2569612930 cites W2330451900 @default.
• W2569612930 cites W2418813771 @default.
• W2569612930 cites W2531524018 @default.
• W2569612930 cites W2914686075 @default.
• W2569612930 cites W4240185141 @default.
• W2569612930 cites W4320288061 @default.
• W2569612930 doi "https://doi.org/10.1136/bmjopen-2016-013967" @default.
• W2569612930 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5253538" @default.
• W2569612930 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28073796" @default.
• W2569612930 hasPublicationYear "2017" @default.
• W2569612930 type Work @default.
• W2569612930 sameAs 2569612930 @default.
• W2569612930 citedByCount "24" @default.
• W2569612930 countsByYear W25696129302017 @default.

• next